- Home
- SHOT vs SCNX Comparison
SHOT vs SCNX Comparison
Compare SHOT & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- SCNX
- Stock Information
- Founded
- SHOT 2018
- SCNX 2010
- Country
- SHOT United States
- SCNX United States
- Employees
- SHOT N/A
- SCNX N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- SHOT Health Care
- SCNX Health Care
- Exchange
- SHOT Nasdaq
- SCNX Nasdaq
- Market Cap
- SHOT 38.9M
- SCNX 33.6M
- IPO Year
- SHOT 2020
- SCNX 2020
- Fundamental
- Price
- SHOT $0.49
- SCNX $1.26
- Analyst Decision
- SHOT
- SCNX
- Analyst Count
- SHOT 0
- SCNX 0
- Target Price
- SHOT N/A
- SCNX N/A
- AVG Volume (30 Days)
- SHOT 707.0K
- SCNX 2.6M
- Earning Date
- SHOT 03-31-2025
- SCNX 03-18-2025
- Dividend Yield
- SHOT N/A
- SCNX N/A
- EPS Growth
- SHOT N/A
- SCNX N/A
- EPS
- SHOT N/A
- SCNX 3.55
- Revenue
- SHOT $652,495.00
- SCNX N/A
- Revenue This Year
- SHOT N/A
- SCNX $1,085.75
- Revenue Next Year
- SHOT N/A
- SCNX N/A
- P/E Ratio
- SHOT N/A
- SCNX $0.57
- Revenue Growth
- SHOT 68.01
- SCNX 166.67
- 52 Week Low
- SHOT $0.41
- SCNX $1.21
- 52 Week High
- SHOT $2.89
- SCNX $34.80
- Technical
- Relative Strength Index (RSI)
- SHOT 47.41
- SCNX N/A
- Support Level
- SHOT $0.43
- SCNX N/A
- Resistance Level
- SHOT $0.60
- SCNX N/A
- Average True Range (ATR)
- SHOT 0.05
- SCNX 0.00
- MACD
- SHOT 0.01
- SCNX 0.00
- Stochastic Oscillator
- SHOT 42.95
- SCNX 0.00
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.